Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers

British Journal of Clinical Pharmacology

Volumn 68, Issue 2, 2009, Pages 201-206

  Lei, He Ping ^a   Ji, Wei ^a   Lin, Jian ^a   Chen, Hao ^a   Tan, Zhi Rong ^a   Hu, Dong Li ^a   Liu, Li Juan ^a   Zhou, Hong Hao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bupropion; Drug interactions; Ginkgo biloba; Hydroxybupropion

Indexed keywords

AMFEBUTAMONE; CYTOCHROME P450 2B6; GINKGO BILOBA EXTRACT; RADAFAXINE; UNCLASSIFIED DRUG; ZYBAN SR;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; GINKGO BILOBA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MEDICINAL PLANT; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADULT; ANTIDEPRESSIVE AGENTS; BUPROPION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPIDEMIOLOGIC METHODS; GINKGO BILOBA; HERB-DRUG INTERACTIONS; HUMANS; MALE; PLANT EXTRACTS; YOUNG ADULT;

EID: 68449095081     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03442.x     Document Type: Article

References (22)

1. Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 1994 11 : 133 41.
2. Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 2000 28 : 1222 30.
3. Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, Greenblatt DJ. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 2000 28 : 1176 83.
4. Faucette SR, Hawke RL, Shord SS, Lecluyse EL, Lindley CM. Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. Drug Metab Dispos 2001 29 : 1123 9.
5. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther 2005 27 : 1685 95.
6. Maclennan KM, Darlington CL, Smith PF. The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 2002 67 : 235 57.
7. Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 2000 81 : 668 78.
8. Joshi BS, Kaul PN. Alternative medicine: herbal drugs and their critical appraisal - Part I. Prog Drug Res 2001 56 : 1 76.
9. Umegaki K, Yoshimura M, Higuchi M, Esashi T, Shinozuka K. Influence of Ginko biloba Extract feeding on blood pressure, heart rate, blood glucose, and various hepatic parameters in spontaneously hypertensive rats. Shokuhin Eiseigaku Zasshi 2000 41 : 171 7.
10. Shinozuka K, Umegaki K, Kubota Y, Tanaka N, Mizuno H, Yamauchi J, Nakamura K, Kunitomo M. Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci 2002 70 : 2783 92.
11. Umegaki K, Saito K, Kubota Y, Sanada H, Yamada K, Shinozuka K. Ginkgo biloba extract markedly induces pentoxyresorufin o-dealkylase activity in rats. Jpn J Pharmacol 2002 90 : 345 51.
12. Loboz KK, Gross AS, Williams KM, Liauw WS, Day RO, Blievernicht JK, Zanger UM, McLachlan AJ. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity. Clin Pharmacol Ther 2006 80 : 75 84.
13. Turpeinen M, Tolonen A, Uusitalo J, Jalonen J, Pelkonen O, Laine K. Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Clin Pharmacol Ther 2005 77 : 553 9.
14. Hogeland GW, Swindells S, McNabb JC, Kashuba AD, Yee GC, Lindley CM. Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects. Clin Pharmacol Ther 2007 81 : 69 75.
15. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005 165 : 296 301.
16. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992 340 : 1136 9.
17. Jacobs BP, Browner WS. Ginkgo biloba: a living fossil. Am J Med 2000 108 : 341 2.
18. De Smet PA. Herbal remedies. N Engl J Med 2002 347 : 2046 56.
19. Palovaara S, Pelkonen O, Uusitalo J, Lundgren S, Laine K. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation. Clin Pharmacol Ther 2003 74 : 326 33.
20. Robertson SM, Davey RT, Voell J, Formentini E, Alfaro RM, Penzak SR. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr Med Res Opin 2008 24 : 591 9.
21. Bal dit Sollier C, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol 2003 25 : 251 3.
22. Markowitz JS, Donovan JL, Lindsay DeVane C, Sipkes L, Chavin KD. Multiple-dose administration of ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003 23 : 576 81.